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Abstract
Background: Against a backdrop of declining tobacco use, e-cigarette markets are growing. The UK now has a
higher percentage of e-cigarette users than any other European country. These developments have prompted
fierce discussions in scientific, advocacy and policy communities about how best to respond. This article is one of
the first to examine the role of evidence in these debates.
Methods: We analysed 121 submissions to two Scottish policy consultations on e-cigarettes (in 2014 and 2015) and
undertook interviews with 26 key informants in 2015–2016, following up with a sub-set in 2019–2020. All data were
thematically coded, and our analysis was informed by insights from policy studies and the sociology of science.
Results: First, we affirm previous research in suggesting that e-cigarettes appeared to have triggered a breakdown
of old public health alliances. Second, we demonstrate that, amid concerns about research quality and quantity,
actors are guided by normative outlooks (and/or economic interests) in their assessments of evidence. Third, we
show that, despite describing e-cigarette debates as contentious and polarised, actors engaging in Scottish policy
debates exhibit a spectrum of views, with most interviewees occupying an uncertain ‘middle ground’ that is
responsive to new evidence. Fourth, we suggest that the perceived divisiveness of e-cigarette debates is attributed
to recurrent media simplifications and tensions arising from the behaviours of some actors with settled positions
working to promote particular policy responses (including by strategically enrolling supportive evidence). Fifth, we
argue that the actions of these actors are potentially explained by the prospect that e-cigarettes could usher in a
new tobacco ‘policy paradigm’. Finally, we show how scientific authority is employed as a tool within these
debates.
Conclusions: E-cigarette debates are likely to reconcile only if a clear majority of participants in the uncertain
‘middle ground’ settle on a more fixed position. Our results suggest that many participants in Scottish e-cigarette
debates occupy this ‘middle ground’ and express concerns that can be empirically assessed, implying evidence has
the potential to play a more important role in settling e-cigarette debates than previous research suggests.
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Background
Electronic devices that mimic aspects of smoking (not-
ably by delivering nicotine via inhalation) have been
around since the late 1960s [1] but e-cigarettes have only
achieved widespread use in the past decade [2, 3]. A
2017 survey found the UK had emerged as the European
country with the greatest proportion (4.7%) of adults
identifying as regular e-cigarette users [2]. The rapid
growth of the e-cigarette market, combined with limited
evidence of the consequences of their use, presents a
range of challenges to public health policymakers and
researchers [4]. Key questions include:
– Should e-cigarettes be banned (as consumer prod-
ucts that enable users to consume an addictive
drug)?
– Alternatively, should e-cigarettes be promoted as a
unique opportunity to support smokers who want to
quit?
– If e-cigarettes are not banned, should they be regu-
lated as tobacco products or medicines or something
else and what does this mean, in practice?
– Will e-cigarettes contribute to a reduction in
smoking?
– Will e-cigarettes sustain addictions and/or attract
new (younger) consumers?
– As tobacco companies expand their market share of
e-cigarettes, will they be able to regain policy cred-
ibility and influence or should Article 5.3 of the glo-
bal Framework Convention on Tobacco Control
apply in excluding them from e-cigarettes policy
discussions?
In attempting to respond to these questions, public
health researchers and policy actors are far from unified,
with different policy bodies and states taking radically dif-
ferent approaches. For example, while Public Health Eng-
land has promoted the relative safety of e-cigarettes
(compared to conventional smoking), supporting calls for
relaxed regulation (e.g. [5, 6]), the US has taken a more re-
strictive approach [7], banning most flavours from 1st
February 2020 [8], while Australia and some US cities and
states have opted to ban their sale entirely [9, 10].
It is not only policymakers who are divided: key char-
ities involved in battling the tobacco epidemic have
come down on different sides of e-cigarette regulatory
debates [11]; media coverage suggests key actors pro-
mote opposing messages [12]; and public health advo-
cates, once allies in the fight to reduce smoking, find
themselves on opposing ‘sides’ [13]. Indeed, as e-
cigarette use rises, the UK tobacco control movement
appears to have transformed from a relatively unified
advocacy-coalition, responsible for achieving major pub-
lic health milestones [14], to a site of contestation and
conflict [11, 13, 15]. Since a more divided tobacco con-
trol movement has long been an aim of transnational to-
bacco companies [16], it is crucial to understand how
and why this fragmentation has occurred.
So far, the rapidly growing evidence-base does not ap-
pear to be resolving matters, at least in the UK. In
Hawkins and Ettelt’s [13] assessment, two distinct
‘camps’ have emerged as evidence has entered the inevit-
ably political space of policy discussions: a ‘harm reduc-
tion’ camp, which is broadly supportive of e-cigarettes
and seeking relaxed regulation, and a ‘precautionary
principle’ camp, which is concerned with the potentially
negative consequences of e-cigarette growth, so pushing
for more stringent regulation. Hawkins and Ettelt argue
that, science and evidence are venerated as ‘a potential
arbiter of policy disputes’ [13, p584], leading actors to
claim that scientific consensus exists, despite the pres-
ence of alternative voices.
In analysing these debates, Hawkins and Ettelt [13]
argue that Rein and Schön’s [17] concept of ‘policy
frames’ helps explain how and why actors in both ‘camps’
are able to use evidence to support their positions; each
set of actors frame the policy problem in contrasting
ways and therefore ask different questions of the available
evidence. Whilst one ‘camp’ focuses on the role
e-cigarettes might play in reducing tobacco-related
harms (seeking evidence regarding the relative harms of
vaping compared to smoking), the other is concerned
with the potential for e-cigarettes to act as a gateway into
smoking for non-smokers, to re-normalise smoking-type
behaviour, and to enable tobacco industry actors to re-
enter research and policy debates. As a result, Hawkins
and Ettelt [13] argue that evidence is unlikely to play a
significant role in arbitrating e-cigarettes debates.
Accounts of the research and policy debates surround-
ing e-cigarettes in the UK [13, 15] contrast sharply with
multiple earlier studies of the tobacco policy field, which
frequently depict public health actors functioning as a
relatively cohesive ‘advocacy coalition’ in the face of to-
bacco industry opposition [18–20]. Several of these older
analyses used Sabatier and Jenkins-Smith’s [21]
advocacy-coalition framework (ACF) to help explain
their findings. The ACF provides a framework for under-
standing policy debates over time. It posits that networks
of diverse actors (including policymakers, researchers,
think tanks, journalists, interest groups and others) form
opposing ‘advocacy coalitions’ that compete to influence
‘policy subsystems’. These ‘advocacy coalitions’ remain
relatively stable over time because they form around
‘policy core’ beliefs which, in turn, reflect members’
‘deep core’ beliefs (strongly held ontological and norma-
tive beliefs, such as a belief concerning the balance be-
tween individuals’ right to freedom versus social
equality). From this perspective, while evidence may
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alter actors’ perceptions of the specific policy tools most
likely to achieve their preferred outcomes, it is unlikely
to alter a coalition’s views on what policy ought to be
trying to achieve (i.e. ultimate policy goals) or broadly
how this might be accomplished, since these beliefs are
grounded in such deeply held values.
This paper draws on document and interview data to
provide the first detailed empirical analysis of the role
that evidence is playing in the contentious policy debates
surrounding e-cigarettes in Scotland, a devolved UK na-
tion with a particularly strong record on public health
and tobacco control [22]. Theoretically, our analysis sug-
gests that utility of the ACF in helping to explain to-
bacco control policy debates is diminishing in the
context of e-cigarettes. Instead, we posit that combining
Hall’s [23] concept of ‘policy paradigms’ and Gieryn’s
[24] concept of scientific ‘boundary work’ together pro-
vide greater analytical insight, especially when it comes
to understanding how scientific authority is employed
within these debates. In the concluding discussion, we
reflect on the implications of our findings for the likely
future of e-cigarette debates in the UK.
Methods
We conducted a thematic analysis of 121 publicly
available documents and interviews with 26 key
informants. The document analysis centred on written
responses to the Scottish Government consultation on
Electronic Cigarettes and Strengthening Tobacco Con-
trol in Scotland [25] and to questions on nicotine
vapour products in the Scottish Parliament Health and
Sports Committee Call for written views on the Health
(Tobacco, Nicotine, etc. & Care) (Scotland) Bill [26].
These documents are publicly available (and we there-
fore identify the organisational authors where we cite
these data).
Figure 1 provides a graphic depiction of the process
of selecting 121 consultation responses for the docu-
mentary analysis. There were 266 consultation re-
sponses overall, but responses from individuals (largely
vapers) were excluded in order to focus our analysis
on the policy debates between organisational actors.
In-depth thematic analysis of free text within the
Scottish Government and Scottish Parliament consult-
ation submissions was undertaken using NVivo11.
Twenty consultation responses were initially coded in-
dependently by two members of the research team to
ascertain policy preferences and references to (and
claims about) evidence. This initial thematic coding
was discussed by the full team to inform the final
coding framework, which was then applied to the full
document set by a single coder (the lead researcher:
Fig. 1 Flowchart of process for selecting documents to include in our analysis
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Theresa Ikegwuonu). The themes of most relevance to
this paper were:
 Difficulties in researching e-cigarettes
 Research funding
 Sources of evidence
 Emerging evidence
 Quality of evidence
 Missing evidence




 Research communication or knowledge exchange
work
 Discrediting or supressing discussion of evidence
 Same evidence used to support opposing views
To select potential interviewees from the consultation
responses, we identified all organisations that had shown
an interest in the process of negotiating and developing
legislation to regulate e-cigarettes in Scotland. Inter-
viewees representing these organisations were subse-
quently selected using purposive sampling to obtain a
varied sample of stakeholders, representing a range of
policy positions and organisation types. Potential inter-
viewees were approached by email or telephone invita-
tion (n = 47), via the project advisory board (n = 8) or via
webchat and LinkedIn (n = 3). Up to three follow-up ap-
proaches were made. When participants agreed to take
part, a suitable date and location for the interview was
arranged. In total, we conducted 25 semi-structured in-
terviews with 26 interviewees (one was a joint interview)
between November 2016 and August 2017 (a generic
version of the interview schedule is available as Add-
itional File 1). Table 1 summarises interviewees, in terms
of organisational sector and organisational positions on
e-cigarette regulation (ascertained from consultation
submissions).
All interviews were recorded and transcribed. We read
and re-read the transcripts prior to the lead researcher
(Theresa Ikegwuonu) developing a thematic coding frame
in NVivo11, which was collectively discussed and agreed
with the full team (in terms of analysing evidence use this
framework largely mirrored the one used to code consult-
ation submissions). We initially coded a sample of nine
transcripts, all of which were cross-checked with a second
team member, after which we discussed and refined the
coding frame. The full set of transcripts were then system-
atically coded by TI using the revised coding frame, with
all team members having access to the NVivo11 file. A
second researcher cross-checked the coding on a sample
of transcripts for consistency. Following data coding, the
key themes of relevance to this paper were analysed by the
lead author (who also read all transcripts in full, for con-
text). The lead author then presented early analysis to the
rest of the research team and to the project’s Advisory
Board, developing this analysis further in response to feed-
back and discussion.
Conscious of the time that had passed since our data
collection, and the speed with which e-cigarette prod-
ucts, markets and debates are evolving, in 2019, we
approached all of our original interviewees with a re-
quest to undertake a follow-up interview. Between Au-
gust 2019 and March 2020, we conducted follow-up
interviews with all those who were available (see Table
1), using a follow-up interview schedule (Add-
itional File 2). This included representatives from eleven
of the original organisations in our interview sample
(seven were individuals from our original set of 26 par-
ticipants, two of whom gave a joint interview at both
stages; five were new interviewees, based at an organisa-
tion in our original sample). This paper primarily fo-
cuses on our original data set but the final section of our
results briefly summarises how follow-up interviewees
suggested debates had evolved since the original data
collection.
This study was reviewed by and obtained ethical ap-
proval from the University of Glasgow’s Social Sciences
Research Ethics Committee.
Finally, given the contested nature of e-cigarettes de-
bates, we feel it is important to acknowledge our own
positionality, before presenting our analysis. As re-
searchers, we are all committed to improving public
health and reducing health inequalities but none of us
has yet reached a clear or fixed position regarding the
potential impact of, or optimal regulatory approach to,
e-cigarettes. Several of us have previously published re-
search that critically examines tobacco industry influ-
ence on public policies and this has left us cautious
about the potential for transnational tobacco companies
to regain public and policy influence via e-cigarette
investments.
Results
The results are organised into six sub-sections, ordered
to help convey the complex and nuanced narrative that
emerged from our analysis. We use the term ‘actors’ to
refer collectively to our interviewees and the authors of
the policy submissions we analysed.
Public health fighting amongst itself: the emergence of e-
cigarettes ruptures an old alliance
In line with the existing literature, both the interviews
and consultation submissions provide copious evidence
of the contested nature of e-cigarettes in Scotland, with
interviewees describing debates as ‘nasty’, ‘unpleasant’
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and ‘horrible’ (see also [15]), and one interviewee claim-
ing that some participants ‘almost feel bullied into si-
lence’. In short, as the following three extracts attest, our
data suggest that the growth of e-cigarettes in the UK
(which has introduced a range of new actors) has caused
a long-standing tobacco control advocacy-coalition to
rupture, with the consequence that previously positive,
collaborative relationships have broken down:
Interviewee 11 (academic researcher): “The […] criti-
cism that we get nowadays is actually from our col-
leagues, it’s from public health, and there are
particular individuals, [gives named examples], who
have been incredibly critical of the position that [we
and others] have taken. They’ve been vicious. They’ve
been insulting. […] So, it’s hugely divisive and I would
say that relationships that used to be very positive –
so I used to have a very positive relationship with
[named example] and that’s not the case anymore –
[…] now it’s public health fighting amongst itself in-
stead of what we used to do, which is we knew who
the enemy was, the enemy was the tobacco industry
and that has… the debate has shifted.”
Interviewee 12 (NHS – National Health Service):
“It’s been a terrible shame actually because having
worked in tobacco control for the twenty years […], I
have never known an issue to cause the divisiveness
that this has caused. […] I mean, I got some feedback
on something which was in an extremely unprofes-
sional manner actually. I was absolutely horrified.
And academics who I have worked with very closely
and very well with, in the past.”
Interviewee 14 (pharmacy): “We tried to do a joint
statement with [a public health organisation] in the
Table 1 Overview of interviewees
Interview
ID
Interviewee classification Organisational position on key e-cigarette issues within consultation submission
Age of sale to under-18 s E-cigarette advertising Vaping in public places
1 Academic group Restrict Restrict N/Aa
2 Third sector/civil society organisationc Restrict Restrict Do not restrict
3 Third sector/civil society organisationc Restrict Restrict Do not restrict
4 Health service [NHS] Restrict Restrict Restrict
5 Third sector/civil society organisation Restrict Restrict Do not restrict
6 Government c N/A N/A N/A
7 Health service providers Do not restrict N/A Restrict
8 E-cigarette industryb d Restrict Do not restrict N/A
9 Academic group N/A Restrict N/A
10 Health service providers Restrict N/A Restrict
11 Academic groups c Restrict N/A N/A
12 Health service [NHS] Restrict Restrict Restrict
13 Health service providers b Restrict Restrict Do not restrict
14 Health service providers b Restrict Restrict Restrict
15 E-cigarette industryb Restrict Do not restrict Do not restrict
16 Retail Restrict Do not restrict Do not restrict
17 Academic group Restrict N/A N/A
18 Tobacco Industry Restrict Do not restrict Do not restrict
19 Third sector/civil society organisationc Restrict Do not restrict Do not restrict
20 Tobacco Industry b Restrict Do not restrict Do not restrict
21 Local authority with remit in health Restrict Restrict Restrict
22 Third sector/civil society organisation Restrict Do not restrict Do not restrict
23 Health service [NHS] Restrict Restrict Restrict
24 Third sector/civil society organisation Restrict Restrict N/A
25 Pharmaceutical manufacturer b N/A N/A N/A
aN/A indicates that no response was given in the consultation submission of the organisation represented by the interviewee. b Signals follow-up interview was
conducted with the original interviewee from this organisation in 2019–2020. c Signals follow-up interview was conducted with a new interviewee from this
organisation in 2019–2020 d Signals joint interview with two participants
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beginning but then we realised that, actually, we’re
coming from two different places. […] Before e-
cigarettes, we would’ve done a joint statement with
[that organisation] very easily because we’re very
much on the same page. We suddenly realised we’re
actually on quite different pages on this, so we
haven’t done anything.”
In Sabatier and Jenkins-Smith’s [21] accounts of the
ACF, the values around which coalitions form are
depicted as so deeply embedded that they are hard to
shift. Yet, our data suggest that the public health coali-
tion broke down relatively easily in the context of e-
cigarettes. This suggests that analyses of the tobacco pol-
icy subsystem prior to the growth of e-cigarettes may
have implied a greater degree of normative coherency
than was necessarily the case [27].
Negotiating the ‘wild west’ of evidence with values,
beliefs and interests
In explaining how they were negotiating the new to-
bacco policy landscape, almost all our interviewees sug-
gested that evidence had an important role to play.
However, there was widespread agreement that available
evidence was limited and not always of high quality:
Interviewee 19 (pro-e-cigarette campaign group):
“The standard of some of the evidence, and to be fair
on both sides, is not great quality...”
Interviewee 4 (NHS): “The evidence is absolutely
rubbish. There’s stuff published which is terrible,
awful studies. People over-egging stuff. People, you
know - it is a kind of Wild West with e-cigarettes,
with people making all sorts of claims about it.”
Interviewees generally attributed the limited quality of
available evidence to the novelty of e-cigarettes, the di-
versity of products captured by the ‘e-cigarettes’ label
and the dynamism of both the market and products,
with several interviewees highlighting the inevitable ab-
sence of long-term evidence. For example:
Interviewee 19 (pro e-cigarette campaign group):
“The evidence that’s missing is about long-term
use, and the consequence and risks associated
with that. And the reality is you can’t have long-
term evidence until the product’s been around for
a long time.”
Interviewee 2 (Third sector health advocacy group):
“You just can’t generalise about this huge range of
devices and then huge range of fluids as well. It’s not
a thing, and that’s what I’m always trying to remind
enquirers, it’s just, it’s not one thing (sigh). […] I
can’t think of any product that’s quite as diverse.”
Despite this consensus, most actors appeared to have
preferred policy positions on key regulatory issues and
most employed evidence to support these positions (this
was true of both interviewees and the organisational
consultation responses). In the following extracts, we see
both interviewees attributing contrasting positions on e-
cigarettes to pre-existing views and values:
Interviewee 5 (Third sector/health charity): “I think
some academics have been so keen to actually gather
evidence which supports their view, rather than
gathering the evidence and letting that form their
view, and I have to confess, I’ve been a bit shocked
at the extent to which I think I’ve seen that take
place.”
Interviewee 1 (academic researcher): “[I]f your basic
premise is inconsistent with use of electronic ciga-
rettes… because you believe that nicotine addiction
is wrong or because you believe that they are a force
of evil… driven by the tobacco industry, then you are
likely to take an extreme view in interpreting evi-
dence that supports those positions.”
Indeed, some of our interviewees openly reflected that,
having settled on a particular policy position, they had
then sought evidence to support it. For example:
Interviewee 1 (academic researcher): “We’re all
guilty of it to some degree, of using evidence to sup-
port an argument rather than basing arguments on
evidence.”
Interviewee 14 (pharmacy sector): “I was trying to
find out more on that side of it, hoping for a few
golden nuggets […] which would support…what we
were trying to say.”
In sum, our data make clear how, in the face of uncer-
tain evidence, actors draw on their beliefs and normative
values to help them make sense of the evidence that is
available. This finding is in line with Sabatier and
Jenkins-Smith’s [21] claim that ‘values’ and ‘beliefs’ shape
policy debates and inform emerging coalitions. Up to
this point, our findings appear to reinforce Hawkins and
Ettelt’s [13] claim that evidence is unlikely to be an ef-
fective arbitrator in the debates surrounding e-cigarettes.
The plot thickens as a hidden ‘middle ground’ emerges
So far, our analysis tells a very similar story to that of
Hawkins and Ettelt [13]: the emergence of e-cigarettes
disrupted old alliances and new divisions emerged as ac-
tors approached the issue (and the evidence) with con-
trasting normative outlooks (or ‘frames’). Yet, in our
data, this narrative only seems to capture the actors who
had settled on clear policy positions about e-cigarettes.
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We were surprised (given the clear sense of divisiveness
that interviewees recounted) to find that our analysis
suggested many participants had not settled in one or
the other of these ‘camps’ and instead self-identified as
occupying a ‘middle ground’. Reflecting this, the follow-
ing interviewee said they felt this was where the majority
of participants in e-cigarette debates (within Scotland)
were positioned:
Interviewee 1 (academic researcher): “There are
some who want very high levels of regulation and
some who feel that we shouldn’t have any regulation
at all […] But […] those are extremes on a spectrum,
and I think most people want proportionate regula-
tion that protects consumers but makes sure the
products stay available.”
Although this claim may, as another interviewee sug-
gested, be partially explained by the strategic value of
self-positioning away from the extremes of a debate, it
nonetheless speaks to the fact that many of our inter-
viewees were resistant to being positioned in either of
the two, opposing ‘camps’ that Hawkins and Ettelt [13]
identified. Moreover, both our documentary and inter-
view data make clear that there were areas of consensus
regarding the regulation of e-cigarettes in Scotland (e.g.
actors generally agreed on the need for age-of-sale
restrictions and, at least partially, on the need to regulate
advertising while only a much smaller number of partici-
pants supported restrictions/bans on vaping in public
places [11]).
Overall, our analysis identified a range of views about
e-cigarettes within our data, each of which was associ-
ated with distinct policy positions. As Fig. 2 depicts,
these views fall along a spectrum. At one end, there are
those whose beliefs and values (and, in some cases, eco-
nomic interests) meant they expressed optimism about
the impacts of e-cigarettes and favoured limited regula-
tion (Position 1 in Fig. 2). At the other end, there were
those who viewed e-cigarettes as a mechanism to main-
tain nicotine addictions and renormalise smoking, who
wanted e-cigarettes to be regulated similarly to trad-
itional tobacco products (Position 4 in Fig. 2). Unsur-
prisingly, those with an economic interest in e-cigarettes
generally expressed views that place them clearly in Pos-
ition 1 (Fig. 2).
Beyond this, however, our data suggest few actors could
be clearly positioned at either end of the spectrum. Rather,
most fell somewhere in the middle, favouring some degree
of regulation but varying in their perspective on specific
regulatory proposals. For these interviewees, the position
their organisation adopted on specific regulatory proposals
in the consultation was often presented as evidence-
informed and open to change.
Fig. 2 The spectrum of actors’ positions on e-cigarettes
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Within this ‘middle ground’, we identified two
dominant positions. The first (Position 2) involved
caution about e-cigarettes on the basis of the potential
harm of the products, mainly in terms of the potential for
e-cigarettes to act as a ‘gateway’ into smoking for non-
smokers and youth but also in terms of renormalising
smoking. The difference between Position 2 and Position
4 is that Position 2 was not informed by a belief that
nicotine addiction is, in principle, undesirable but about
concerns with e-cigarette products that could more easily
be empirically assessed. In contrast, Position 4’s concern
with nicotine addiction effectively ruled e-cigarettes as
undesirable by virtue of the fact they are largely designed
to deliver nicotine to users. Position 3 is placed closer to
the right-hand side than Position 2 as it is underpinned
by a principle of tobacco industry exclusion that suggests
less openness to limited regulation than Position 2.
Importantly, our data suggest that it was not always
possible to place actors at specific points along the
spectrum (Fig. 2). Rather, some consultation re-
sponses and interview transcripts cut across Positions
2 and 3, which makes sense when we consider the
underlying normative outlook associated with the dif-
ferent positions. While Positions 2 and 3 are distinct
from one another (and not interdependent), they are
also compatible. In contrast, the normative outlooks
underpinning Position 1 (harm reduction should be
prioritised) and Position 4 (addictive consumption
products should be tightly regulated) make these posi-
tions incompatible, regardless of any insights provided
by evidence. Only a small number of actors occupied
Position 4, while many of the actors whose views
placed them clearly at Position 1 (Fig. 2) had material
economic interests in the e-cigarette market. Actors
occupying Positions 2–4 all supported greater regula-
tion of e-cigarettes than actors at Position 1, with the
strength and extent of desired regulations increasing
with position number (i.e. those favouring the strictest
regulation occupied Position 4).
All this suggests that, while positions within e-
cigarette debates are shaped by normative outlooks
and material interests, many actors’ positions are
more fluid and intersecting than Hawkins and Ettelt
[13] suggest, making the potential for alliances more
complex. Crucially, while Hawkins and Ettelt [13]
were pessimistic about the potential for evidence to
play a role in arbitrating e-cigarette debates, our data
suggest that research can inform (and, indeed, has in-
formed) actors’ policy positions, especially for actors
occupying the uncertain ‘middle ground’ (Positions 2
and 3 in Fig. 2). In the following extract, for example,
an interviewee reflects that their organisation has
shifted from Position 2 towards Position 1, in light of
emerging evidence:
Interviewee 10 (health service provider): “Going
back to where we started to look at this, one of the
biggest concerns seemed to be about children and
young people using these products as a gateway. And
we’ve monitored the data very closely and talked to
other groups […] and it’s very obvious that the data
in the UK doesn’t suggest that’s a problem, and con-
sistently so. […] So where I think in the past we were
certainly talking about regulating [e-cigarettes] very
strongly to ensure the gateway effect didn’t happen,
we’re very clear now that the evidence and data just
has… there’s probably enough years of it and it
hasn’t shown that to be a big issue.”
Actors whose economic interests were intertwined with
the success of e-cigarettes and those whose normative
outlooks placed them firmly at either end of the spectrum
in Fig. 2 seem unlikely to adapt their position in response
to evidence. However, given most of the actors in our
sample were positioned in the more uncertain ‘middle
ground’, and most referred to research as meaningful, our
data suggest that evidence could play an important role in
the evolution of e-cigarettes policy debates.
Theoretically, our analysis in this section suggests that
the e-cigarettes market has introduced complex dynam-
ics to the tobacco policy and advocacy field. As a conse-
quence, Sabatier and Jenkins-Smith’s [21] widely
employed ACF no longer seems like a sufficient theoret-
ical tool for understanding tobacco policy debates since,
rather than two clear ‘advocacy coalitions’ with distinct
values, our analysis suggests there are at least four dis-
tinct positions, informed by a complex interaction of
values, interests and uncertainties. We return to and de-
velop this analysis in our concluding discussion.
Caught in the crossfire and forced to choose sides
Since our analysis suggests that many of the actors en-
gaging in Scottish policy debates about e-cigarettes oc-
cupy a fluid and uncertain ‘middle ground’ (Fig. 2), this
raises questions as to why our interviewees ([and others:
[15]) describe e-cigarette debates in the UK as so divisive
and antagonistic. In our data, interviewees suggested not
that most actors had chosen ‘sides’ but rather that it was
difficult to avoid being positioned by others as being on
one or the other ‘side’ of e-cigarette debates. In the fol-
lowing extract, for example, an interviewee reflects that
they felt even the act of seeking academic advice could
lead others to (mis)position the advice-seeker:
Interviewee 12 (NHS): “I just do not want involve-
ment with being perceived to be on one side or the
other […] which makes it slightly difficult because
where I would probably naturally want to involve
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academics in certain issues [… but] if you get in-
volved with one academic, then the perception is,
that’s your approach. When actually, it’s not.”
Another interviewee – an academic who said they
tried to speak to ‘both sides’ - was concerned about
how they might be represented in our research as a
consequence of this.
Interviewees attributed the difficulty in avoiding be-
ing positioned on one or the other ‘side’ to two
sources: (i) mass media coverage of e-cigarette de-
bates; and (ii) the behaviour of other actors. On the
first of these, multiple interviewees noted the large
appetite for stories about e-cigarettes in the UK
media and said they felt stories (and sometimes uni-
versity or journal press releases) tried to position
everyone as being in favour or against e-cigarettes (a
perception that analysis of UK newspapers supports
–[7]). For example:
Interviewee 10 (Health Professional Body): “It’s at
times been particularly divisive and not always a
hundred percent clear why, and […] actually, some-
times the positions of organisations aren’t as far
apart, when you look at the detail, as they might
seem. When you have people looking for a high level
kind of position or you get, again, media reports of
your position, they tend to focus on the extreme as-
pects or the kind of overarching headlines, rather
than the detail, and I understand that, but I cer-
tainly think it’s been a real issue on this area.”
Interviewee 1 (academic researcher): “[I]n studies of
children’s use and gateway progression […] the evi-
dence published to date doesn’t support that that is
happening to any significant degree. But that’s not
what you would think, […] reading the press releases
that go with papers.”
The second explanation interviewees gave for the diffi-
culty they faced in avoiding being positioned at either
end of the spectrum related to behaviours and actions of
some of the other actors (including academics) engaging
in e-cigarettes debates. As the opening section of our re-
sults make clear, some interviewees described other ac-
tors in ways that suggested they were working to attract
support for their preferred position, while undermining
opposing positions. Here, the interview data were at
their most critical. While one interviewee described the
situation as ‘healthy debate’, several others expressed
frustration, surprise, exasperation and annoyance at the
behaviours they had witnessed and heard about (see also
the extracts in the opening section of the results):
Interviewee 12 (NHS): “[T]he examples of what I
have seen […] and what I’ve heard in terms of re-
ports of events and the way people have been treated
if they don’t subscribe to a particular line. I’ve also
had a look at, well I did and I haven’t gone back to
look at it again, because I was so horrified at what I
saw, but just some Twitter accounts of the latest re-
search that has come out about things and […] just
comments around those issues and, yeah, it’s shocked
me.”
The claim that media interest in e-cigarette debates
served to unhelpfully simplify debates by positioning ac-
tors as ‘for’ or ‘against’ e-cigarettes is unsurprising since
it is in line with existing analyses of mass media cover-
age of other scientific debates (e.g. [28]). However, the
claim that key actors, including academics, were working
hard to attract others to one side or the other requires
further explanation.
High stakes as a ‘policy paradigm’ shift looms
Our interviewees did not generally proffer their own ex-
planations as to why they felt some actors were working
to attract others to particular ends of the spectrum (Fig.
2) or why, as described at the start of the results and
elsewhere [15] e-cigarettes debates seemed to be associ-
ated with higher than usual instances of emotive, some-
times unpleasant, interactions. Our analysis here is
therefore a little more speculative but the data do sug-
gest that at least some interviewees believed there was a
great deal at stake, variously describing the need to get
the regulatory approach ‘right’ as ‘crucial’ and ‘vitally im-
portant’. We can also see examples of interviewees
reflecting on the possibility that previously accepted te-
nets of tobacco control policy may shift in the context of
e-cigarettes. For example, in the following extract, an
interviewee muses whether the emergence of e-
cigarettes may require a change to the public health con-
sensus around excluding tobacco industry interests from
research and policy discussions:
Interviewee 1 (academic researcher): “It becomes dif-
ficult. So suppose… British American Tobacco were
to buy Johnson & Johnson nicotine replacement ther-
apy range… and became one of the biggest suppliers
of medicinal nicotine in the UK, how would we react
then? And that, so there would need to be some sort
of change in the way that we dealt with tobacco in-
dustry in those circumstances. At the moment, the
tobacco industry, or until now, has made it very easy
for us to portray them as evil and […] organisations
that we shouldn’t have anything to do with because
they haven’t produced any products that we actually
Smith et al. BMC Public Health          (2021) 21:362 Page 9 of 16
want. But whether they’re in that situation now is
far from clear...”
Several interviewees, including the one quoted above,
questioned whether tobacco control may need to alter
its approach to excluding commercial interests, given
the tobacco industry’s new role in e-cigarettes. In contrast,
others emphasised some of the successes of tobacco con-
trol to date, noted previous efforts by tobacco industry ac-
tors to prevent and undermine tobacco control efforts,
and stated they felt there remains a clear need to protect
public health from tobacco industry influence (see Pos-
ition 3 in Fig. 2). This division speaks to Studlar and Cair-
ney’s [29] analysis of tobacco policy development, in
which they propose that the current ‘policy paradigm’,
which views tobacco as a ‘social and global menace’, may
soon evolve. While one possibility would be for the
current paradigm to transition into a ‘neo-prohibitionist’
paradigm, in which further and stronger tobacco control
policies are pursued, they also identify a possibility of a
more ‘radical’ shift to a ‘harm reduction’ policy paradigm.
The concept of a ‘policy paradigm’ comes from Hall
[23] who, employing economic policy as a case study,
showed that policymakers tend to work within particular
interpretative frameworks of ideas that he called ‘policy
paradigms’:
‘Like a Gestalt, this framework is embedded in the
very terminology through which policymakers com-
municate their work, and it is influential precisely
because so much of it is taken for granted and un-
amenable to scrutiny...’ (Hall, 1993, p279).
Viewed from this perspective, policy responses to the
growth of e-cigarettes in the UK could involve one of
three options: (i) the current policy paradigm continues
and e-cigarettes become part of the existing ‘smoking
cessation toolbox’ (interviewee 14 – pharmacy); (ii) e-
cigarettes are tightly regulated, possibly banned, as pol-
icy shifts to a ‘neo-prohibitionist’ paradigm; or (iii) e-
cigarette growth continues and informs a shift to a new
‘harm reduction’ policy paradigm (Studlar and Cairney,
2014). In our data, there was very little evidence of ac-
tors working to actively promote a shift towards a ‘neo-
prohibitionist’ policy paradigm (although some sugges-
tions for a tobacco control 'end game' do posit this kind
of shift, e.g. [30]). However, it was clear that some inter-
viewees were openly identifying perceived failures of
existing policy approaches; a development that Hall
(1990) argues forms an important component of work to
establish a new policy paradigm:
Interviewee 25 (industry manufacturer association):
“If you look at the smoking rates… they are going
down which is good, but it’s a really big health in-
equalities issue, and the people in the kind of poorer,
more deprived areas have much higher smoking
rates than the people in the more affluent areas. So
whilst the overall trend is down, I think that there’s
a lot still that needs to be done to support those
people that are still smoking to become free of that
addiction.”
Some interviewees, such as the following, explicitly
used claims about the failure of current approaches as a
rationale for considering new approaches:
Interviewee 1 (academic researcher): “I’ve been pro-
moting harm reduction as an alternative strand or a
complementary strand to tobacco control ‘cause we
aren’t doing enough for people who are addicted to
tobacco. We’re doing quite well at preventing smok-
ing uptake but we’re not doing very well at helping
established smokers to quit. And harm reduction is
an opportunity to do that.”
To explore this further, Fig. 3 summarises the two
‘policy paradigms’ that were most evident in our
data: the existing ‘tobacco control’ paradigm and a
potential ‘harm reduction’ alternative, which was ac-
tively being promoted by several interviewees and
consultation respondents. At this stage, it is far from
clear that a new ‘harm reduction’ policy paradigm
will emerge. However, the extracts in this section are
illustrative of the fact that some of our interviewees
suggested that we may be on the cusp of significant
changes in the way we think about tobacco policy.
From the perspective of the ‘policy paradigms’ literature
it is unsurprising that e-cigarettes debates feel divisive since,
at least for those clearly favouring one ‘paradigm’ over the
other, the stakes are very high. Where potential policy para-
digm shifts emerge, Hall [23] suggests that advocates of
competing policy paradigms are unlikely to agree on a com-
mon body of evidence (or even data) to adjudicate, making
sociological and political dimensions crucial to understand-
ing how debates evolve. Within this, Hall argues that ‘issues
of authority will be central’, meaning the ‘policy community
will engage in a contest for authority over the issues at
hand’ [23]. Unsurprisingly, for an issue so core to public
health, our data suggest contests for authority in e-cigarette
debates are centred on contrasting claims to scientific au-
thority, even though these debates are often entangled with
more normative divisions (notably around the appropriate
role of tobacco industry actors in policy discussions).
A scientific showdown ensues
Reflecting the importance of scientific authority for pub-
lic health, we found scientific evidence regularly being
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enlisted by actors to support their positions. Indeed, for
each e-cigarette regulatory issue, we can find submis-
sions expressing directly contrasting preferences, each
citing supporting evidence. The following two extracts -
responses to consultation questions about restricting
vaping in enclosed public places - are illustrative:
“Recent research suggests that the second-hand
smoke from some e-cigarettes may contain higher
levels of certain harmful metals than in traditional
tobacco cigarettes […]. Coupled with this, the
World Health Organisation has already proposed
banning the use of e-cigarettes indoors as they in-
crease the background level of toxicants and nico-
tine. Children in Scotland believes that in light of
this evidence that there should be further regulation
of e-cigarettes.” (Children in Scotland).
“E-cigarette vapour does contain toxicants however
this is usually at levels which are far lower than
those found in tobacco cigarettes. […] The consen-
sus is that any harm from e-cigarettes is likely to be
far less than that from tobacco. Therefore, we be-
lieve that there is currently insufficient evidence to
justify a ban on the use of e-cigarettes indoors and
in enclosed public spaces on the basis of harm from
second-hand vapour.” (Cancer Research UK).
For the most part, where this occurred, participants ei-
ther appeared to be drawing on different sources of evi-
dence or framing the implications of the same evidence
in contrasting ways due to the normative lens through
which they were interpreting it. However, we also found
occasional examples of evidence being actively misrepre-
sented. For example, a consultation submission from
Totally Wicked Ltd. claimed that research undertaken
by John Moores University demonstrated that there is
no correlation between electronic cigarette advertising
and use amongst children when, on checking the ori-
ginal qualitative research [31], we found that it did not
assess correlation between exposure to advertising and
use. Decisions to misrepresent research as supporting a
particular position speaks to the importance that those
involved in e-cigarettes policy debates attach to being
able to claim positions are evidence-based.
Interestingly, where actors acknowledged that evidence
was lacking, our data provide examples of this absence
being employed to reach directly opposing conclusions,
as Fig. 4 illustrates. Although public health is, as a dis-
cipline and area of practice, strongly committed to the
idea of evidence-informed decision-making, Fig. 4 high-
lights that early evidence in contentious policy areas (or
the associated lack of evidence) is not necessarily a tool
that can easily settle policy controversies. Indeed, as
Fig. 3 Two competing ‘policy paradigms’ in the tobacco field
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Table 2 illustrates, the data are replete with examples of
participants affirming the scientific credibility of their
preferred position and, in some cases, discrediting the
scientific credentials of those with alternative positions.
Such accounts are examples of what Gieryn terms
scientific ‘boundary work’, in which participants con-
struct a ‘boundary’ between ‘science’ and ‘non-science’
to reinforce the authority of their preferred perspec-
tive [24]. Although Gieryn’s focus was restricted to
scientists themselves (and not linked to Hall’s work
on ‘policy paradigms’), his account of ‘boundary work’
makes clear why such an approach might be attractive
for participants seeking to promote a particular policy
paradigm:
‘when the goal is monopolization of professional au-
thority and resources, boundary-work excludes ri-
vals […] by defining them as outsiders with labels
such as “pseudo,” “deviant,” or “amateur”’.
In fact, there are so many examples of ‘boundary work’
in action within our data that it is impossible to include
them all so, for brevity, Table 2 summarises illustrative
data extracts of key types of ‘boundary work’ that we
identified.
Overall, while there are occasional references to
markers of scientific credibility relating to methods
and processes in our data (e.g. one reference to the
peer-review process and another highlighting the
credibility of systematic reviews compared to single
studies), we can also see (in Table 2) that perceptions
of scientific authority and credibility are closely inter-
twined with people’s sense of ‘trust’ which, in turn,
appeared to rest heavily on personal-professional rela-
tionships and perceptions of independence, expertise
and intelligence.
A temporary lull before post-Brexit battles?
Revisiting our earlier conversations with a sub-set of
follow-up interviewees in 2019–2020 suggests that, while
e-cigarette products and markets have continued to
evolve, the intensity of policy discussions has temporar-
ily abated. The primary explanation for this seemed to
be the fact that initial UK regulatory responses have
been agreed and enacted. Additionally, interviewees sug-
gested other issues had distracted attention from e-
cigarettes, including the emergence of cannabis related
products and the need for broader organisational prepa-
rations for the UK’s exit from the European Union (and,
indeed, some of our potential follow-up interviewees
were unable to participate as a result of the need to
focus on organisational work relating to the COVID-19
pandemic).
No follow-up interviewee suggested there had been
any significant new primary studies, though several
noted there had been some major reviews to synthesise
available evidence [32]. Interviewees did not suggest any
key players within Scotland had made major changes to
Fig. 4 Illustrative examples of the way in which some actors used a lack of evidence to support opposing regulatory positions
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their policy positions on e-cigarettes but some inter-
viewees suggested that a couple of health actors who
had been in the middle of Fig. 2 had shifted somewhat
to the left-hand side, as some of their initial concerns
had been allayed. In contrast, another noted that a spate
of deaths related to vaping in the US [33] may have reig-
nited some concerns about the safety of e-cigarettes.
When it comes to the potential for research to address
these concerns, several interviewees confirmed their
earlier view that only longitudinal research, over a gener-
ation, was likely to settle these debates.
Overall, despite some feeling that media outlets con-
tinued to present e-cigarettes as divisive, our follow-up
interviews suggested research and policy debates were
less fraught in 2019–20 than they had been in 2016–17
but that this was due to reduced policy activity, rather
than to substantial shifts in the positions of key players
or the emergence of any research consensus. For now, e-
cigarettes appear to have been accommodated within the
UK’s dominant tobacco control policy paradigm, as a
means of enabling smokers to reduce or quit smoking.
However, it was also clear that post-Brexit regulatory
discussions are being positioned as an opportunity for
changing the UK’s regulatory approach to e-cigarettes.
Indeed, it was notable that interviewees involved in the
e-cigarettes industry were already expressing some
Table 2 Illustrative examples of ‘boundary work’ in e-cigarette debates.
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confidence that post-Brexit changes will enable the fur-
ther promotion and growth of e-cigarettes in the UK.
One interviewee also noted ongoing discussions about
the possibility of prescribing e-cigarettes via the National
Health Service. All of this suggests that any lull in policy
debates about e-cigarettes is likely to be temporary.
Discussion
In an overview of sociology of science, Pinch and Leuen-
berger argue that: ‘By studying a scientific controversy
one learns something about the underlying dynamics of
science and technology and their relations with wider
society’, including ‘the normally hidden social dimen-
sions of science’ [34]. In this case, our data suggest that
the emergence of e-cigarettes in the UK has contributed
to a fracturing of a long-standing public health alliance
[18, 19, 27] in ways that imply the actors involved held
distinct values and beliefs, which are being illuminated
via the new questions, opportunities and challenges that
e-cigarettes throw up.
The ensuing debates have clearly been fraught and,
like Hawkins and Ettelt [13], we found those who have
settled on positions at either end of the regulatory
spectrum (particularly those favouring relaxed regula-
tion, many of whom have vested economic interests)
tend to employ evidence strategically, in support of their
preferred position. For these actors, it seems unlikely
that new evidence will inform their preferences regard-
ing the policy response to e-cigarettes. Yet, we also dem-
onstrate that most participants were in an uncertain
‘middle ground’ regarding the regulation of e-cigarettes.
For these actors in the middle ground, even though nor-
mative outlooks often appeared to be helping them to
negotiate the current (limited) evidence-base, most
seemed responsive to emerging evidence (indeed, some
recounted already having altered their position on e-
cigarette regulations in response to new evidence). Our
analysis therefore tells a more complex story than that
of Hawkins and Ettelt [13]; one that is more optimistic
about the role that research evidence is playing in
informing people’s positions on regulation. While we
agree that potential for evidence to adjudicate areas of
clear disagreement or points of principle is limited, our
analysis suggests evidence could play an important role
in shaping the policy preferences of those whose views
about e-cigarettes regulation are less settled.
In theoretical terms, our analysis suggests that Sabatier
and Jenkins-Smith’s ACF, which had previously been
widely applied to analyses of tobacco policy debates [18,
19, 27], sheds only limited light on this field in the con-
text of e-cigarettes. Although the emphasis that the ACF
places on analysing values and interests remains useful,
our findings suggest that the sense of antagonism and
controversy in Scottish e-cigarettes debates comes not
from the existence of two opposing coalitions but from
recurrent media simplifications and the work of some
actors at either end of the regulatory spectrum to bolster
support for their preferred positions. Our analysis sug-
gests that combining Hall’s [23] concept of ‘policy para-
digms’ with Gieryn’s [24] notion of ‘boundary work’ is
analytically more helpful. We argue the sense of
antagonism that marks UK e-cigarette debates, and the
behaviours of some actors, arises from the potential for
e-cigarettes to usher in a new ‘policy paradigm’ for to-
bacco. Hence, engaging with e-cigarettes debates means
engaging with this broader struggle, making the stakes
very high for those who favour one paradigm over the
other. Within this, as Hall [23] suggests, we see claims
to scientific authority serving as a crucial tool in a battle
for authority. Here, we demonstrated the utility of Gier-
yn’s [24] concept of ‘boundary work’ in understanding
how and why actors claim scientific authority for their
own position, while trying to undermine the scientific
claims of opponents.
Looking to the future, our findings suggest that e-
cigarette debates are likely to settle only when a majority
of participants in the uncertain ‘middle ground’ agree a
more concrete position along the spectrum depicted in
Fig. 2. Settling in a more certain ‘middle’ may enable the
current paradigm to continue (as appears to be the case
for now), while a shift to the left-hand side of Fig. 2
(where most of the actors with an economic interest in
e-cigarettes are positioned) seems likely to usher in a
harm reduction paradigm, and a shift to the right-hand
side (more unlikely, given the small number of actors we
identified as openly holding this position), a more neo-
prohibitionist paradigm. There is a potential for evidence
to play an important role here, given that a large number
of actors is occupying the uncertain ‘middle ground’.
Viewed optimistically, this suggests research evidence
could play a role in overcoming the fragmentation of the
UK’s previously strong tobacco control coalition [27]; a
fragmentation which is clearly in tobacco industry inter-
ests [16].
In the meantime, our follow-up interviews suggest
that policy debates are experiencing a temporary lull,
during which time there is a reduced spotlight on
the ‘scientific showdowns’ we identified. However,
these ‘scientific showdowns’ seem likely to re-
intensify as new (e.g. post-Brexit) policy debates de-
velop. This means evidence will continue to be con-
structed and interpreted by actors against a tense
backdrop of contrasting claims to scientific authority.
The importance attached to scientific authority in
public health policy means academics are key actors
in these debates and future research should explore
not only how actors are deploying evidence in policy
debates but also how and why the e-cigarettes
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evidence-base is being constructed as it is, by whom
and to what ends.
Conclusions
Our data support previous research in identifying pol-
icy debates around e-cigarette as highly contentious
[13]. Indeed, we show that previously cohesive to-
bacco control coalitions have unravelled as some ac-
tors, with clear preferences regarding policy responses
to e-cigarettes, have worked hard to influence those
with less fixed views. However, our findings are more
optimistic regarding the potential role of evidence in
resolving public health fragmentation around e-
cigarettes. This is because our results suggest that
many participants in Scottish e-cigarette debates have
not yet reached a settled position on regulating e-
cigarettes and instead occupy an uncertain ‘middle
ground’ which, crucially, appears to be responsive to
emerging evidence.
Supplementary Information
The online version contains supplementary material available at https://doi.
org/10.1186/s12889-021-10396-6.
Additional file 1. Generic version of the main interview schedule, which
lists the questions we put to interviewees (NB as is usual with semi-
structured, qualitative interviews, the ordering and specific wording of
the questions was sometimes tweaked to allow the interviewer to main-
tain the flow of the conversation and ensure questioning was responsive
to information the interviewee provided).
Additional file 2. Generic version of the follow-up interview schedule,
used in the follow-up interviews conducted August 2019–March 2020.
Abbreviations
ACF: Advocacy Coalition Framework; NHS: National Health Service (UK)
Acknowledgements
We gratefully acknowledge the feedback of the members of the scientific
advisory board on the study design, methodology, preliminary findings, and
final version of the manuscript. We would also like to thank all the
interviewees who participated in this research and Dr. Mark Wong, at the
University of Glasgow, who contributed to data analysis in the broader
project.
Authors’ contributions
The research project on which this paper is based was conceived by HW,
who was the original PI and the person to whom Cancer Research UK
awarded funding. SH and KS contributed to the more detailed research
design in the post-award stage and SH became the project PI mid-way
through the project, when HW moved to Germany. TI was the lead research
and undertook the data collection and led on data coding. All authors con-
tributed to checking the coding and analysing the data. KS conceived this
paper and was the lead author, producing the first draft and overseeing all
subsequent edits. SH, TI and HW all contributed to drafting the paper. All au-
thors have read and approved the final manuscript.
Funding
This project was funded by a CRUK Tobacco Advisory Group Project Award
C54625/A20494. SH and TI were part funded by the UK Medical Research
Council (MC_UU_12017/15) and the Chief Scientist Office of the Scottish
Government Health Directorates (SPHSU15 and SPHSU13) at the MRC/CSO
Social and Public Health Sciences Unit, University of Glasgow. The funding
bodies played no role in the design of the study or in the collection,
analysis, and interpretation of data or in writing the manuscript.
Availability of data and materials
The policy consultations analysed in this paper are publicly available
documents which can be accessed here: https://www.gov.scot/publications/
consultation-electronic-cigarettes-strengthening-tobacco-control-responses/
and here: http://www.parliament.scot/parliamentarybusiness/
CurrentCommittees/91459.aspx. The participants who took part as
interviewees consented to participate on the basis that: (i) they would
remain anonymous; and (ii) the full data would only be available to the
research team and only anonymised extracts would be published (since
publishing the full transcripts would be likely to reveal interviewees’
identities, at least to others working in this field). All research team members
have seen the full interview transcripts.
Ethics approval and consent to participate
This study was reviewed by and obtained ethical approval from the
University of Glasgow’s Social Sciences Research Ethics Committee. All
interview participants provided informed consent before undertaking the
interview (via a signed consent form). The interviews were all conducted by




We declare no competing interests.
Author details
1School of Social Work & Social Policy, University of Strathclyde, Lord Hope
Building, 141 St James Road, Glasgow G4 0LT, UK. 2MRC/CSO Social and
Public Health Sciences Unit, University of Glasgow, Berkeley Square, 99
Berkeley Street, Glasgow G3 7HR, UK.
Received: 22 May 2020 Accepted: 5 February 2021
References
1. Cummings KM, Dresler CM, Field JK, Fox J, Gritz ER, Hanna NH, Ikeda N,
Jassem J, Mulshine JL, Peters MJ, et al. E-cigarettes and Cancer patients. J
Thorac Oncol. 2014;9(4):438–41.
2. Laverty AA, Filippidis FT, Vardavas CI. Patterns, trends and determinants of
e-cigarette use in 28 European Union member states 2014–2017. Prev Med.
2018;116:13–8.
3. Yoong SL, Stockings E, Chai LK, Tzelepis F, Wiggers J, Oldmeadow C, Paul C,
Peruga A, Kingsland M, Attia J et al: Prevalence of electronic nicotine
delivery systems (ENDS) use among youth globally: a systematic review and
meta-analysis of country level data 2018, 42(3):303–308.
4. Berridge V. Electronic cigarettes and history. Lancet. 2014;383(9936):2204–5.
5. McNeill A, Brose LS, Calder R, Bauld L, Robson D. Evidence review of e-
cigarettes and heated tobacco products 2018 - a report commissioned by
Public Health England. In. London: Public Health England; 2018.
6. Public Health England. E-cigarettes: a new foundation for evidence-based
policy and practice. London: Public Health England; 2015.
7. Office of the Surgeon General: E-Cigarette Use Among Youth and Young
Adults: A Report of the Surgeon General. In. Rockville, MD: U.S. Department
of Health and Human Services; 2016.
8. Tanne JH: FDA bans most flavoured e-cigarettes as lung injury epidemic
slows. 2020, 368:m12.
9. Hotten R: San Francisco becomes first US city to ban e-cigarettes. In: BBC
News. https://www.bbc.co.uk/news/business-48752929; 2019.
10. House of Representatives Standing Committee on Health ACaS: Report on
the Inquiry into the Use and Marketing of Electronic Cigarettes and
Personal Vaporisers in Australia. In. Canberra: Parliament of the
Commonwealth of Australia,; 2018.
11. Weishaar HB, Ikegwuonu T, Smith KE, Buckton CH, Hilton S. E-cigarettes: a
disruptive technology? An Analysis of Health Actors’ Positions on E-
Cigarette Regulation in Scotland. Int J Environ Res Public Health. 2019;
16(17):3103.
Smith et al. BMC Public Health          (2021) 21:362 Page 15 of 16
12. Patterson C, Hilton S, Weishaar H. Who thinks what about e-cigarette
regulation? A content analysis of UK newspapers. Addiction. 2016;111(7):
1267–74.
13. Hawkins B, Ettelt S. The strategic uses of evidence in UK e-cigarettes policy
debates. Evidence & Policy. 2019;15(4):579–96.
14. Joossens L, Feliu A, Fernandez E. The tobacco control scale 2019 in Europe.
In. Brussels: Association of European Cancer Leagues & Catalan Institute of
Oncology; 2020.
15. Lucherini M. Caught in the middle: early career researchers, public health
and the emotional production of research. Crit Public Health. 2018:1–6.
16. McDaniel PA, Smith EA, Malone RE. Philip Morris’s Project Sunrise:
weakening tobacco control by working with it. Tob Control. 2006;15(3):215–
23.
17. Rein M, Schön D. Frame reflection: towards the resolution of intractable
policy controversies. New York: Basic Books; 1994.
18. Farquharson K. Influencing policy transnationally: pro-and anti-tobacco
global advocacy networks. Aust J Public Adm. 2003;62(4):80–92.
19. Princen S. Advocacy coalitions and the internationalization of public health
policies. J Public Policy. 2007;27:13–33.
20. Weishaar H, Amos A, Collin J. Best of enemies: using social network analysis
to explore a policy network in European smoke-free policy. Soc Sci Med.
2015;133:85–92.
21. Sabatier PA, Jenkins-Smith HC. Policy learning and change: an advocacy
coalition approach. Boulder: Westview Press; 1993.
22. Smith KE, Collin J. Scotland and the public health politics of independence.
BMJ. 2013;347:f7595.
23. Hall PA. Policy paradigms, social learning, and the state: the case of
economic policymaking in Britain. Comparative Politics. 1993;25(3):275–96.
24. Gieryn TF. Boundary-work and the demarcation of science from non-
science: strains and interests in professional ideologies of scientists. Am
Sociol Rev. 1983;48(6):781–95.
25. The Scottish Government: A Consultation on Electronic Cigarettes and
Strengthening Tobacco Control in Scotland. In. Edinburgh: Tobacco Control
Policy Team; 2014.
26. The Scottish Parliament: Health (Tobacco, Nicotine etc. and Care)(Scotland)
Bill - Call for written evidence. In. https://www.parliament.scot/parliamenta
rybusiness/CurrentCommittees/91073.aspx: The Scottish Parliament; 2015.
27. Smith KE: Understanding the Influence of Evidence in Public Health Policy:
What Can We Learn from the ‘Tobacco Wars’? 2013, 47(4):382–398.
28. Boyce T. In: Lewis J, editor. climate change and the media. New York: Peter
Lang; 2009.
29. Studlar DT, Cairney P. Conceptualizing punctuated and non-punctuated
policy change: tobacco control in comparative perspective. International
Review of Administrative Sciences. 2014;80(3):513–31.
30. McDaniel PA, Smith EA, Malone RE. The tobacco endgame: a qualitative
review and synthesis. Tob Control. 2016;25:594–604.
31. Hardcastle K, Hughes K, Worsley J, Bennett A, Ireland R, Sweeney S. "Most
people I know have got one" - young People's perceptions and experiences
of electronic cigarettes summary report. Liverpool: Health Equalities Group;
2014.
32. The National Academies of Sciences E, and Medicine (NASEM),: Public
health consequences of e-cigarettes. In. Washington, DC: The National
Academies Press; 2018.
33. US Centers for Disease Control and Prevention: Outbreak of lung injury
associated with e-cigarette use, or vaping, products. In. Atlanta, GA: US
Centers for Disease Control and Prevention; 2019.
34. Pinch T, Leuenberger C: Studying Scientific Controversy from the STS
Perspective. In: Paper presented at the EASTS Conference "Science Controversy
and Democracy". National Taiwan University, Taiwan: http://sts.nthu.edu.tw/
easts/conference.htm 2006.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Smith et al. BMC Public Health          (2021) 21:362 Page 16 of 16
